STAT3 and cancer: Aberrant constant activation of STAT3 has been observed in several human cancers, including ovarian, head and neck, breast, or lung cancers, driving multiple oncogenic pathways (Sonnenblick et al., 2012; Harada et al., 2014; Geiger et al., 2016; Saini et al., 2017).